| GENERIC NAME | This data is not available for free |
| STRUCTURE | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo- 3H-indol-3-ylidine)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide malate |
| INDICATION'S |
Oncology> - Advanced Renal Cell Carcinoma - GastroIntestinal Stromal Tumor |
| MECHANISM OF ACTION | Flk-1 (VEGF R2)>AngioGenesis Inhibition |
| SIDE EFFECT'S | Heart Risks? |
| STATUS |
JP>Approved USA>Approved: 01.26.06. US Expiration: 02.15.2021 |
| UPDATE | 2017. 11.16 |
| COMPANY | This data is not available for free |
| PATENT NUMBER | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |